AUTHOR=Xu Meng , Guan Xiao 

TITLE=Aurintricarboxylic Acid Suppresses Hepatitis B Virus Replication by Inhibition of RNase H Activity

JOURNAL=Frontiers in Virology

VOLUME=Volume 2 - 2022

YEAR=2022

URL=https://www.frontiersin.org/journals/virology/articles/10.3389/fviro.2022.861494

DOI=10.3389/fviro.2022.861494

ISSN=2673-818X

ABSTRACT=Background: Chronic hepatitis B virus (HBV) infection is a global health threat, for which there are urgent needs to develop novel therapeutics. 
Methods: The aurintricarboxylic acid (ATA) has been demonstrated with broad-spectrum antimicrobial and antiviral activities. In this study we implemented ATA treatment in HBV-infected and -transfected hepatocytes to uncover whether ATA inhibits HBV replication and its underlying mechanism.
Results: HBV DNA levels were significantly reduced while viral proteins or transcripts were not altered. In contrast, ATA treatment did not further deteriorate HBV DNAs, viral proteins and transcripts in hepatocytes transfected by an HBV RNase H dead mutant. Moreover, ATA showed an inhibitory effect on DNA synthesis in hepatocytes transfected with lamivudine-resistant HBV mutants. 
Conclusions: ATA is a potent inhibitor of HBV replication by disrupting the RNase H activity of viral polymerase.